A Randomized control trial to evaluate Human papillomavirus (HPV) DNA self-sampling as a primary cervical screening test in wome

Not Applicable

Completed

• Conditions: Cervical Cancer; Human papillomavirus (HPV); Cancer - Cervical (cervix); Public Health - Health service research

• Registration Number: ACTRN12613001003763
• Lead Sponsor: Professor Eliza LY Wong, Associate Professor

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-09-10
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 390

Inclusion Criteria

Female aged 35 to 65 who have ever had sexual experience and are able to give a written informed consent.

Exclusion Criteria

Women who have never had sex, had total hysterectomy, or currently pregnant were excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Participants' acceptability towards HPV DNA self-sampling vs clinician sampling. Each participant was asked the acceptability towards both sampling methods, by means of face-to-face interview using a structured questionnaire. After having both screening tests performed, they were again asked the acceptability and preferences toward both methods.[same day as the screening was done, after obtaining all samples]

Secondary Outcome Measures

Name	Time	Method
Evaluation of the accuracy of self-collected vaginal samples for HPV DNA testing in comparison to clinician-obtained cervical samples [After obtaining all samples]